Ticker Scorecard - ORIC Basics Company: Oric Pharmaceuticals, Inc. IPO Date: April 24, 2020 Sector: Healthcare Industry: Biotech Market Cap: $545.49M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.65% Avg Daily Range (30 D): $0.58 | 5.80% Avg Daily Range (90 D): $0.38 | 3.95% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): 1.2M Avg Daily Volume (90 D): .6M Trade Size Avg Trade Size (Sh.): 87 Avg Trade Size (Sh.) (30 D): 97 Avg Trade Size (Sh.) (90 D): 82 Institutional Trades Total Inst.Trades: 651 Avg Inst. Trade: $1.5M Avg Inst. Trade (30 D): $.87M Avg Inst. Trade (90 D): $.92M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.84M Avg Closing Trade (30 D): $.93M Avg Closing Trade (90 D): $.92M Avg Closing Volume: 142.12K     News Feb 7, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire Jan 3, 2025 @ 9:30 PM ORIC Pharmaceuticals Reports Inducement Grants ... Source: Oric Pharmaceuticals, Inc. Nov 20, 2024 @ 12:00 PM C4 Therapeutics Appoints Accomplished Oncology Exe... Source: N/A Oct 4, 2024 @ 8:30 PM ORIC Pharmaceuticals Reports Inducement Grants und... Source: Oric Pharmaceuticals, Inc. Financials   TTM Q4 2024 FY 2024 Basic EPS $-1.83 $-.51 $-1.83 Diluted EPS $-1.83 $-.51 $-1.83 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -127.85M $ -36.31M $ -127.85M Operating Income / Loss $ -142.9M $ -39.57M $ -142.9M Cost of Revenue $ $ $ Net Cash Flow $ 36.02M $ 15.18M $ 36.02M PE Ratio